Table 1 Patients’ and treatment related characteristics (n = 26).
Age at recurrence, years, median (range) | 54 (33–75) |
BMI in kg/m2, median (range) | 33.1 (20.2–46.5) |
Menopausal status at diagnosis | |
Premenopause, n (%) | 17 (65.4) |
Postmenopause, n (%) | 9 (34.6) |
Initial stage (FIGO), n (%) | |
1a | 16 (61.5) |
1c1 | 3 (11.5) |
1c3 | 1 (3.9) |
2b | 1 (3.9) |
3a | 1 (3.9) |
3c | 4 (15.4) |
Residual disease after primary surgery, n (%) | |
Tumor free/optimal | 24 (92.3) |
Suboptimal | 2 (7.7) |
LND at initial surgery, n (%) | 2 (7.7) |
Initial fertility sparing surgery (FSS), n (%) | 7 (26.9) |
Adjuvant therapy after primary surgery, n (%) | |
Cytotoxic chemotherapy (Carboplatin and taxol) | 4 (15.4) |
Antihormonal therapy | 1 (3.9) |
Chemotherapy + antihormonal therapy | 1 (3.9) |
Time from diagnosis to first relapse, in months, median (range) | 83 (6–336) |
Follow up period (from first relapse), months, median (range) | 80 (12–193) |
